Google-Backed AI Drug Discovery Startup Raises $600 Million
(Reuters) - Isomorphic Labs, which uses artificial intelligence technologies for drug discovery, has raised $600 million in its first ever external funding round led by Thrive Capital, the startup ...
腾讯网27 天
AI结构预测的边界：AlphaFold为何不能取代实验结构生物学
本文将探讨获得2024年诺贝尔化学奖的蛋白质结构预测工具AlphaFold和传统的结构生物学方法的对比。 AlphaFold是由DeepMind开发的AI模型，能够根据蛋白质 ...
Nature5 天
AlphaFold is running out of data — so drug firms are building their own version
AlphaFold, the revolutionary, Nobel prize-winning tool for predicting protein structures, has a problem: it’s running low on data. The latest version of the artificial intelligence (AI) model ...
新浪网1 个月
AI结构预测的边界：AlphaFold为何不能取代实验结构生物学
AlphaFold是由DeepMind开发的AI模型，能够根据蛋白质的氨基酸序列预测其三维结构。蛋白质就像是生命体内的小机器，它们的结构决定了功能。了解蛋白 ...
The Scientist3 个月
Artificial Intelligence in Biology: From Neural Networks to AlphaFold
Researchers press on with the refinement of AI models, addressing their limitations and demonstrating widespread applications in biology. With the 2018 release of AlphaFold, an AI deep learning model, ...
pharmaphorum5 天
AlphaFold 3 takes structure predictions well beyond proteins
The latest version of Google DeepMind and Isomorphic Labs’ AlphaFold model can predict the structure and relationships not only of proteins, but “all of life’s molecules”, according to its ...